Integrated Diagnostics Holdings (LSE:IDHC) EV-to-OCF: (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:IDHC Integrated Diagnostics Holdings PLC LSE:IDHC
62 GF Score
Price $0.52
GF Value $0.60
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Integrated Diagnostics Holdings EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Integrated Diagnostics Holdings's Enterprise Value is $308.13 Mil. Integrated Diagnostics Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil. Therefore, Integrated Diagnostics Holdings's EV-to-OCF for today is .

The historical rank and industry rank for Integrated Diagnostics Holdings's EV-to-OCF or its related term are showing as below:

LSE:IDHC' s EV-to-OCF Range Over the Past 10 Years
Min: -69.86   Med: 12.72   Max: 62.54
Current: 7.9

During the past 13 years, the highest EV-to-OCF of Integrated Diagnostics Holdings was 62.54. The lowest was -69.86. And the median was 12.72.

LSE:IDHC's EV-to-OCF is ranked worse than
53.3% of 212 companies
in the Medical Diagnostics & Research industry
Industry Median: 6.235 vs LSE:IDHC: 7.90

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-18), Integrated Diagnostics Holdings's stock price is $0.52. Integrated Diagnostics Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.016. Therefore, Integrated Diagnostics Holdings's PE Ratio (TTM) for today is 32.50.

Integrated Diagnostics Holdings  (LSE:IDHC) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Integrated Diagnostics Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.52/0.016
=32.50

Integrated Diagnostics Holdings's share price for today is $0.52.
Integrated Diagnostics Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.016.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Integrated Diagnostics Holdings EV-to-OCF Related Terms

Integrated Diagnostics Holdings EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Integrated Diagnostics Holdings's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrated Diagnostics Holdings EV-to-OCF Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.77 48.04 13.47 8.51 10.93

Integrated Diagnostics Holdings Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Dec25 Mar26
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.03 8.51 32.55 10.93 0.00

LSE:IDHC vs TMO, DHR, IDXX: EV-to-OCF Comparison

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Integrated Diagnostics Holdings EV-to-OCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's EV-to-OCF falls into.


LSE:IDHC
62GF Score
Integrated Diagnostics Holdings PLC LSE:IDHC
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrated Diagnostics Holdings EV-to-OCF Calculation

Integrated Diagnostics Holdings's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=308.130/0
=

Integrated Diagnostics Holdings's current Enterprise Value is $308.13 Mil.
Integrated Diagnostics Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Integrated Diagnostics Holdings (LSE:IDHC) Overvalued in 2026?

Based on GuruFocus' analysis, Integrated Diagnostics Holdings stock appears to be undervalued. The current stock price of $0.52 is trading 13.3% below its estimated GF Value™ of $0.60. GuruFocus considers Integrated Diagnostics Holdings to be Modestly Undervalued.

Key valuation signals for LSE:IDHC:

  • EV-to-OCF:
  • GF Value™: $0.60 vs. price of $0.52 (13.3% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the LSE:IDHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integrated Diagnostics Holdings Business Description

Address 12 Castle Street, St Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments: the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.
62GF Score

Get the complete analysis for LSE:IDHC

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.52
Price
$0.60
GF Value